What is Biomyx?
Biomyx is a biotechnology firm dedicated to advancing functional genomics and biomedical research through innovative technologies. Their core offerings include cost-effective siRNA technology, precise site-specific protein ligation tools, and essential reagents for stem cell research. Complementing their product line, Biomyx also offers expert professional services in molecular and cell biology, catering to researchers and institutions within the life sciences. The company's commitment is to provide high-quality, user-friendly solutions that accelerate scientific discovery.
How much funding has Biomyx raised?
Biomyx has raised a total of $14K across 1 funding round:
Debt
$14K
Debt (2021): $14K with participation from PPP
Key Investors in Biomyx
PPP
Public-Private Partnership
What's next for Biomyx?
With the recent capital injection, Biomyx is poised for significant expansion. The Series A/B growth stage funding will likely be allocated towards enhancing their product development pipeline, scaling manufacturing capabilities, and broadening their market penetration. Strategic investments in research and development are anticipated to drive the creation of next-generation tools for genomics and biomedical applications. Furthermore, the company may explore strategic partnerships to amplify its impact and reach within the global life sciences community.
See full Biomyx company page
